Juventas Therapeutics Garners $5,000,000 New Funding

  • Feed Type
  • Date
    11/21/2013
  • Company Name
    Juventas Therapeutics
  • Mailing Address
    3615 Superior Avenue Cleveland, OH 44114
  • Company Description
    Juventas Therapeutics is a privately held biotechnology company developing a pipeline of regenerative therapies to treat life–threatening diseases. The company’s lead product, Stromal–cell Derived Factor 1 (SDF–1), has been shown to protect and repair tissue following organ–damage in a broad range of pre–clinical disease models.
  • Website
    http://www.Juventasinc.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.